Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-10

Clinical Trial Update: Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased Risk [NA]

View source ↗

Summary

A clinical trial comparing fenretinide followed by preventive surgery versus preventive surgery alone in women at high risk for ovarian cancer has been terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fenretinide (fenretinide)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Ovarian Cancer | NA | Status: TERMINATED